View in EDS

A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.

Saved in:
Bibliographic Details
Title: A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
Authors: Harvey VJ; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland. Electronic address: vernonh@adhb.govt.nz., Sharples KJ; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland; Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin., Isaacs RJ; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North., Jameson MB; Waikato Regional Cancer Centre, Waikato Hospital, Hamilton., Jeffery GM; Oncology Service, Christchurch Hospital, Christchurch., McLaren BR; Southern Blood and Cancer Service, Dunedin Hospital, Dunedin., Pollard S; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Riley GA; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Simpson AB; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., Hinder VA; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Scott JN; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland., Dzhelali MV; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand., Findlay MP; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Jul; Vol. 24 (7), pp. 1828-1834. Date of Electronic Publication: 2013 Mar 04.
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23463624
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Harvey+VJ%22">Harvey VJ</searchLink>; Regional Cancer and Blood Centre, Auckland City Hospital, Auckland. Electronic address: vernonh@adhb.govt.nz.<br /><searchLink fieldCode="AU" term="%22Sharples+KJ%22">Sharples KJ</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland; Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin.<br /><searchLink fieldCode="AU" term="%22Isaacs+RJ%22">Isaacs RJ</searchLink>; Midcentral Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North.<br /><searchLink fieldCode="AU" term="%22Jameson+MB%22">Jameson MB</searchLink>; Waikato Regional Cancer Centre, Waikato Hospital, Hamilton.<br /><searchLink fieldCode="AU" term="%22Jeffery+GM%22">Jeffery GM</searchLink>; Oncology Service, Christchurch Hospital, Christchurch.<br /><searchLink fieldCode="AU" term="%22McLaren+BR%22">McLaren BR</searchLink>; Southern Blood and Cancer Service, Dunedin Hospital, Dunedin.<br /><searchLink fieldCode="AU" term="%22Pollard+S%22">Pollard S</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.<br /><searchLink fieldCode="AU" term="%22Riley+GA%22">Riley GA</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.<br /><searchLink fieldCode="AU" term="%22Simpson+AB%22">Simpson AB</searchLink>; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hinder+VA%22">Hinder VA</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.<br /><searchLink fieldCode="AU" term="%22Scott+JN%22">Scott JN</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.<br /><searchLink fieldCode="AU" term="%22Dzhelali+MV%22">Dzhelali MV</searchLink>; Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Findlay+MP%22">Findlay MP</searchLink>; Cancer Trials New Zealand, Division of Oncology, University of Auckland, Auckland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2013 Jul; Vol. 24 (7), pp. 1828-1834. <i>Date of Electronic Publication: </i>2013 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23463624
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdt065
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1828
    Titles:
      – TitleFull: A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Harvey VJ
      – PersonEntity:
          Name:
            NameFull: Sharples KJ
      – PersonEntity:
          Name:
            NameFull: Isaacs RJ
      – PersonEntity:
          Name:
            NameFull: Jameson MB
      – PersonEntity:
          Name:
            NameFull: Jeffery GM
      – PersonEntity:
          Name:
            NameFull: McLaren BR
      – PersonEntity:
          Name:
            NameFull: Pollard S
      – PersonEntity:
          Name:
            NameFull: Riley GA
      – PersonEntity:
          Name:
            NameFull: Simpson AB
      – PersonEntity:
          Name:
            NameFull: Hinder VA
      – PersonEntity:
          Name:
            NameFull: Scott JN
      – PersonEntity:
          Name:
            NameFull: Dzhelali MV
      – PersonEntity:
          Name:
            NameFull: Findlay MP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2013 Jul
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1